Literature DB >> 3341693

Cyclosporin in Wegener granulomatosis.

F Gremmel, W Druml, P Schmidt, W Graninger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3341693     DOI： 10.7326/0003-4819-108-3-491_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Cyclosporin in Wegener's granulomatosis with renal failure.

Authors:  J C Borleffs; J C van der Zwan
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  The treatment of Wegener's granulomatosis.

Authors:  R A DeRemee
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

Review 3.  Respiratory diseases.

Authors:  D G James; O M Sharma
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

4.  Relapsing Wegener's granulomatosis: successful treatment with cyclosporin-A.

Authors:  C Georganas; D Ioakimidis; C Iatrou; B Vidalaki; K Iliadou; P Athanassiou; T Kontomerkos
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

Review 5.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 6.  The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.

Authors:  Cecilia Beatrice Chighizola; Voon H Ong; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 10.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.